Compile Data Set for Download or QSAR
Report error Found 75 Enz. Inhib. hit(s) with all data for entry = 9998
TargetHistamine H1 receptor(Human)
Alairion

US Patent
LigandChemical structure of BindingDB Monomer ID 506794BDBM506794(US11046651, Compound 12)
Affinity DataKi:  13nMAssay Description:1 μl of a compounds of the present disclosure and either reference compound (Table C) were transferred to assay plates. 1 μl of 0.2 mM Keta...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Alairion

US Patent
LigandChemical structure of BindingDB Monomer ID 506772BDBM506772(US11046651, Compound 1)
Affinity DataKi:  13nMAssay Description:1 μl of a compounds of the present disclosure and either reference compound (Table C) were transferred to assay plates. 1 μl of 0.2 mM Keta...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Alairion

US Patent
LigandChemical structure of BindingDB Monomer ID 506773BDBM506773(US11046651, Compound 13)
Affinity DataKi:  13nMAssay Description:1 μl of a compounds of the present disclosure and either reference compound (Table C) were transferred to assay plates. 1 μl of 0.2 mM Keta...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Alairion

US Patent
LigandChemical structure of BindingDB Monomer ID 506774BDBM506774(US11046651, Compound 2)
Affinity DataKi:  13nMAssay Description:1 μl of a compounds of the present disclosure and either reference compound (Table C) were transferred to assay plates. 1 μl of 0.2 mM Keta...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Alairion

US Patent
LigandChemical structure of BindingDB Monomer ID 506775BDBM506775(US11046651, Compound 14)
Affinity DataKi:  13nMAssay Description:1 μl of a compounds of the present disclosure and either reference compound (Table C) were transferred to assay plates. 1 μl of 0.2 mM Keta...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Alairion

US Patent
LigandChemical structure of BindingDB Monomer ID 506776BDBM506776(US11046651, Compound 3)
Affinity DataKi:  13nMAssay Description:1 μl of a compounds of the present disclosure and either reference compound (Table C) were transferred to assay plates. 1 μl of 0.2 mM Keta...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Alairion

US Patent
LigandChemical structure of BindingDB Monomer ID 506777BDBM506777(US11046651, Compound 15)
Affinity DataKi:  13nMAssay Description:1 μl of a compounds of the present disclosure and either reference compound (Table C) were transferred to assay plates. 1 μl of 0.2 mM Keta...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Alairion

US Patent
LigandChemical structure of BindingDB Monomer ID 506778BDBM506778(US11046651, Compound 4)
Affinity DataKi:  13nMAssay Description:1 μl of a compounds of the present disclosure and either reference compound (Table C) were transferred to assay plates. 1 μl of 0.2 mM Keta...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Alairion

US Patent
LigandChemical structure of BindingDB Monomer ID 506780BDBM506780(US11046651, Compound 5)
Affinity DataKi:  13nMAssay Description:1 μl of a compounds of the present disclosure and either reference compound (Table C) were transferred to assay plates. 1 μl of 0.2 mM Keta...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Alairion

US Patent
LigandChemical structure of BindingDB Monomer ID 506781BDBM506781(US11046651, Compound 17)
Affinity DataKi:  13nMAssay Description:1 μl of a compounds of the present disclosure and either reference compound (Table C) were transferred to assay plates. 1 μl of 0.2 mM Keta...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Alairion

US Patent
LigandChemical structure of BindingDB Monomer ID 506782BDBM506782(US11046651, Compound 6)
Affinity DataKi:  13nMAssay Description:1 μl of a compounds of the present disclosure and either reference compound (Table C) were transferred to assay plates. 1 μl of 0.2 mM Keta...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Alairion

US Patent
LigandChemical structure of BindingDB Monomer ID 506784BDBM506784(US11046651, Compound 7)
Affinity DataKi:  13nMAssay Description:1 μl of a compounds of the present disclosure and either reference compound (Table C) were transferred to assay plates. 1 μl of 0.2 mM Keta...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Alairion

US Patent
LigandChemical structure of BindingDB Monomer ID 506785BDBM506785(US11046651, Compound 19)
Affinity DataKi:  13nMAssay Description:1 μl of a compounds of the present disclosure and either reference compound (Table C) were transferred to assay plates. 1 μl of 0.2 mM Keta...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetHistamine H1 receptor(Human)
Alairion

US Patent
LigandChemical structure of BindingDB Monomer ID 506778BDBM506778(US11046651, Compound 4)
Affinity DataKi:  13nMAssay Description:1 μl of a compounds of the present disclosure and either reference compound (Table C) were transferred to assay plates. 1 μl of 0.2 mM Keta...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetHistamine H1 receptor(Human)
Alairion

US Patent
LigandChemical structure of BindingDB Monomer ID 506781BDBM506781(US11046651, Compound 17)
Affinity DataKi:  13nMAssay Description:1 μl of a compounds of the present disclosure and either reference compound (Table C) were transferred to assay plates. 1 μl of 0.2 mM Keta...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetHistamine H1 receptor(Human)
Alairion

US Patent
LigandChemical structure of BindingDB Monomer ID 506782BDBM506782(US11046651, Compound 6)
Affinity DataKi:  13nMAssay Description:1 μl of a compounds of the present disclosure and either reference compound (Table C) were transferred to assay plates. 1 μl of 0.2 mM Keta...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetHistamine H1 receptor(Human)
Alairion

US Patent
LigandChemical structure of BindingDB Monomer ID 506783BDBM506783(US11046651, Compound 18)
Affinity DataKi:  13nMAssay Description:1 μl of a compounds of the present disclosure and either reference compound (Table C) were transferred to assay plates. 1 μl of 0.2 mM Keta...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetHistamine H1 receptor(Human)
Alairion

US Patent
LigandChemical structure of BindingDB Monomer ID 506790BDBM506790(US11046651, Compound 10)
Affinity DataKi:  13nMAssay Description:1 μl of a compounds of the present disclosure and either reference compound (Table C) were transferred to assay plates. 1 μl of 0.2 mM Keta...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2C(Human)
Alairion

US Patent
LigandChemical structure of BindingDB Monomer ID 506798BDBM506798(US11046651, Compound 29)
Affinity DataKi:  13nMAssay Description:1 μL of a compound of the present disclosure the reference compound (Table J) was transferred to an assay plate. 1 μL of 0.2 mM SB-206533 w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2C(Human)
Alairion

US Patent
LigandChemical structure of BindingDB Monomer ID 506799BDBM506799(US11046651, Compound 31)
Affinity DataKi:  13nMAssay Description:1 μL of a compound of the present disclosure the reference compound (Table J) was transferred to an assay plate. 1 μL of 0.2 mM SB-206533 w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2C(Human)
Alairion

US Patent
LigandChemical structure of BindingDB Monomer ID 506800BDBM506800(US11046651, Compound 33)
Affinity DataKi:  13nMAssay Description:1 μL of a compound of the present disclosure the reference compound (Table J) was transferred to an assay plate. 1 μL of 0.2 mM SB-206533 w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2C(Human)
Alairion

US Patent
LigandChemical structure of BindingDB Monomer ID 506801BDBM506801(US11046651, Compound 34)
Affinity DataKi:  13nMAssay Description:1 μL of a compound of the present disclosure the reference compound (Table J) was transferred to an assay plate. 1 μL of 0.2 mM SB-206533 w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2C(Human)
Alairion

US Patent
LigandChemical structure of BindingDB Monomer ID 506793BDBM506793(US11046651, Compound 38)
Affinity DataKi:  13nMAssay Description:1 μL of a compound of the present disclosure the reference compound (Table J) was transferred to an assay plate. 1 μL of 0.2 mM SB-206533 w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2C(Human)
Alairion

US Patent
LigandChemical structure of BindingDB Monomer ID 506795BDBM506795(US11046651, Compound 39)
Affinity DataKi:  13nMAssay Description:1 μL of a compound of the present disclosure the reference compound (Table J) was transferred to an assay plate. 1 μL of 0.2 mM SB-206533 w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetHistamine H1 receptor(Human)
Alairion

US Patent
LigandChemical structure of BindingDB Monomer ID 506772BDBM506772(US11046651, Compound 1)
Affinity DataKi:  13nMAssay Description:1 μl of a compounds of the present disclosure and either reference compound (Table C) were transferred to assay plates. 1 μl of 0.2 mM Keta...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Alairion

US Patent
LigandChemical structure of BindingDB Monomer ID 506788BDBM506788(US11046651, Compound 9)
Affinity DataKi:  13nMAssay Description:1 μl of a compounds of the present disclosure and either reference compound (Table C) were transferred to assay plates. 1 μl of 0.2 mM Keta...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Alairion

US Patent
LigandChemical structure of BindingDB Monomer ID 506790BDBM506790(US11046651, Compound 10)
Affinity DataKi:  13nMAssay Description:1 μl of a compounds of the present disclosure and either reference compound (Table C) were transferred to assay plates. 1 μl of 0.2 mM Keta...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Alairion

US Patent
LigandChemical structure of BindingDB Monomer ID 506792BDBM506792(US11046651, Compound 11)
Affinity DataKi:  13nMAssay Description:1 μl of a compounds of the present disclosure and either reference compound (Table C) were transferred to assay plates. 1 μl of 0.2 mM Keta...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Alairion

US Patent
LigandChemical structure of BindingDB Monomer ID 506787BDBM506787(US11046651, Compound 20)
Affinity DataKi:  37.5nMAssay Description:1 μl of a compounds of the present disclosure and either reference compound (Table C) were transferred to assay plates. 1 μl of 0.2 mM Keta...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetHistamine H1 receptor(Human)
Alairion

US Patent
LigandChemical structure of BindingDB Monomer ID 506780BDBM506780(US11046651, Compound 5)
Affinity DataKi:  37.5nMAssay Description:1 μl of a compounds of the present disclosure and either reference compound (Table C) were transferred to assay plates. 1 μl of 0.2 mM Keta...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2C(Human)
Alairion

US Patent
LigandChemical structure of BindingDB Monomer ID 506797BDBM506797(US11046651, Compound 28)
Affinity DataKi:  37.5nMAssay Description:1 μL of a compound of the present disclosure the reference compound (Table J) was transferred to an assay plate. 1 μL of 0.2 mM SB-206533 w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Alairion

US Patent
LigandChemical structure of BindingDB Monomer ID 506789BDBM506789(US11046651, Compound 21)
Affinity DataKi:  37.5nMAssay Description:1 μl of a compounds of the present disclosure and either reference compound (Table C) were transferred to assay plates. 1 μl of 0.2 mM Keta...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetHistamine H1 receptor(Human)
Alairion

US Patent
LigandChemical structure of BindingDB Monomer ID 506785BDBM506785(US11046651, Compound 19)
Affinity DataKi:  37.5nMAssay Description:1 μl of a compounds of the present disclosure and either reference compound (Table C) were transferred to assay plates. 1 μl of 0.2 mM Keta...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2C(Human)
Alairion

US Patent
LigandChemical structure of BindingDB Monomer ID 506802BDBM506802(US11046651, Compound 35)
Affinity DataKi:  37.5nMAssay Description:1 μL of a compound of the present disclosure the reference compound (Table J) was transferred to an assay plate. 1 μL of 0.2 mM SB-206533 w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetHistamine H1 receptor(Human)
Alairion

US Patent
LigandChemical structure of BindingDB Monomer ID 506786BDBM506786(US11046651, Compound 8)
Affinity DataKi:  37.5nMAssay Description:1 μl of a compounds of the present disclosure and either reference compound (Table C) were transferred to assay plates. 1 μl of 0.2 mM Keta...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetHistamine H1 receptor(Human)
Alairion

US Patent
LigandChemical structure of BindingDB Monomer ID 506773BDBM506773(US11046651, Compound 13)
Affinity DataKi:  37.5nMAssay Description:1 μl of a compounds of the present disclosure and either reference compound (Table C) were transferred to assay plates. 1 μl of 0.2 mM Keta...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetHistamine H1 receptor(Human)
Alairion

US Patent
LigandChemical structure of BindingDB Monomer ID 506774BDBM506774(US11046651, Compound 2)
Affinity DataKi:  37.5nMAssay Description:1 μl of a compounds of the present disclosure and either reference compound (Table C) were transferred to assay plates. 1 μl of 0.2 mM Keta...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Alairion

US Patent
LigandChemical structure of BindingDB Monomer ID 506783BDBM506783(US11046651, Compound 18)
Affinity DataKi:  37.5nMAssay Description:1 μl of a compounds of the present disclosure and either reference compound (Table C) were transferred to assay plates. 1 μl of 0.2 mM Keta...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetHistamine H1 receptor(Human)
Alairion

US Patent
LigandChemical structure of BindingDB Monomer ID 506776BDBM506776(US11046651, Compound 3)
Affinity DataKi:  37.5nMAssay Description:1 μl of a compounds of the present disclosure and either reference compound (Table C) were transferred to assay plates. 1 μl of 0.2 mM Keta...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetHistamine H1 receptor(Human)
Alairion

US Patent
LigandChemical structure of BindingDB Monomer ID 506786BDBM506786(US11046651, Compound 8)
Affinity DataKi:  46nMAssay Description:1 μl of a compounds of the present disclosure and either reference compound (Table C) were transferred to assay plates. 1 μl of 0.2 mM Keta...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2C(Human)
Alairion

US Patent
LigandChemical structure of BindingDB Monomer ID 506784BDBM506784(US11046651, Compound 7)
Affinity DataKi: >50nMAssay Description:1 μL of a compound of the present disclosure the reference compound (Table J) was transferred to an assay plate. 1 μL of 0.2 mM SB-206533 w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetHistamine H1 receptor(Human)
Alairion

US Patent
LigandChemical structure of BindingDB Monomer ID 506795BDBM506795(US11046651, Compound 39)
Affinity DataKi: >50nMAssay Description:1 μl of a compounds of the present disclosure and either reference compound (Table C) were transferred to assay plates. 1 μl of 0.2 mM Keta...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2C(Human)
Alairion

US Patent
LigandChemical structure of BindingDB Monomer ID 506786BDBM506786(US11046651, Compound 8)
Affinity DataKi: >50nMAssay Description:1 μL of a compound of the present disclosure the reference compound (Table J) was transferred to an assay plate. 1 μL of 0.2 mM SB-206533 w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2C(Human)
Alairion

US Patent
LigandChemical structure of BindingDB Monomer ID 506791BDBM506791(US11046651, Compound 37)
Affinity DataKi: >50nMAssay Description:1 μL of a compound of the present disclosure the reference compound (Table J) was transferred to an assay plate. 1 μL of 0.2 mM SB-206533 w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Alairion

US Patent
LigandChemical structure of BindingDB Monomer ID 506779BDBM506779(US11046651, Compound 16)
Affinity DataKi: >50nMAssay Description:1 μl of a compounds of the present disclosure and either reference compound (Table C) were transferred to assay plates. 1 μl of 0.2 mM Keta...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetHistamine H1 receptor(Human)
Alairion

US Patent
LigandChemical structure of BindingDB Monomer ID 506775BDBM506775(US11046651, Compound 14)
Affinity DataKi: >50nMAssay Description:1 μl of a compounds of the present disclosure and either reference compound (Table C) were transferred to assay plates. 1 μl of 0.2 mM Keta...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetHistamine H1 receptor(Human)
Alairion

US Patent
LigandChemical structure of BindingDB Monomer ID 506777BDBM506777(US11046651, Compound 15)
Affinity DataKi: >50nMAssay Description:1 μl of a compounds of the present disclosure and either reference compound (Table C) were transferred to assay plates. 1 μl of 0.2 mM Keta...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Alairion

US Patent
LigandChemical structure of BindingDB Monomer ID 506786BDBM506786(US11046651, Compound 8)
Affinity DataKi: >50nMAssay Description:1 μl of a compounds of the present disclosure and either reference compound (Table C) were transferred to assay plates. 1 μl of 0.2 mM Keta...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

TargetHistamine H1 receptor(Human)
Alairion

US Patent
LigandChemical structure of BindingDB Monomer ID 506779BDBM506779(US11046651, Compound 16)
Affinity DataKi: >50nMAssay Description:1 μl of a compounds of the present disclosure and either reference compound (Table C) were transferred to assay plates. 1 μl of 0.2 mM Keta...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Alairion

US Patent
LigandChemical structure of BindingDB Monomer ID 506791BDBM506791(US11046651, Compound 37)
Affinity DataKi: >50nMAssay Description:1 μl of a compounds of the present disclosure and either reference compound (Table C) were transferred to assay plates. 1 μl of 0.2 mM Keta...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/27/2021
Entry Details
US Patent

Displayed 1 to 50 (of 75 total ) | Next | Last >>
Jump to: